Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Class IIa HDACs – new insights into their functions in physiology and pathology
Maribel Parra
FEBS Journal (2014) Vol. 282, Iss. 9, pp. 1736-1744
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park, Jeong‐Sun Kim
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 2, pp. 204-212
Open Access | Times Cited: 370
Metabolic Regulation of Histone Post-Translational Modifications
Jing Fan, Kimberly A. Krautkramer, Jessica L. Feldman, et al.
ACS Chemical Biology (2015) Vol. 10, Iss. 1, pp. 95-108
Open Access | Times Cited: 299
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Genes (2020) Vol. 11, Iss. 5, pp. 556-556
Open Access | Times Cited: 271
Regulation of Class IIa HDAC Activities: It is Not Only Matter of Subcellular Localization
Eros Di Giorgio, Claudio Brancolini
Epigenomics (2016) Vol. 8, Iss. 2, pp. 251-269
Open Access | Times Cited: 116
Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)
Chunlong Zhao, Hang Dong, Qifu Xu, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 4, pp. 263-274
Closed Access | Times Cited: 112
The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell–dependent emphysema
Wen Lu, Ran You, Xiaoyi Yuan, et al.
Nature Immunology (2015) Vol. 16, Iss. 11, pp. 1185-1194
Open Access | Times Cited: 110
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
Nicola Amodio, Maria Angelica Stamato, Annamaria Gullà, et al.
Molecular Cancer Therapeutics (2016) Vol. 15, Iss. 6, pp. 1364-1375
Open Access | Times Cited: 103
Protein acetylation and deacetylation: An important regulatory modification in gene transcription (Review)
Can Xia, Tao Yu, Mingshan Li, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 100
Nuts and bolts of the salt-inducible kinases (SIKs)
Nicola J. Darling, Philip Cohen
Biochemical Journal (2021) Vol. 478, Iss. 7, pp. 1377-1397
Open Access | Times Cited: 92
Homology modeling andin silicodesign of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes
Ammar D. Elmezayen, Kemal Yelekçi
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 17, pp. 6396-6414
Closed Access | Times Cited: 90
AMPK/Snf1 signaling regulates histone acetylation: Impact on gene expression and epigenetic functions
Antero Salminen, Anu Kauppinen, Kai Kaarniranta
Cellular Signalling (2016) Vol. 28, Iss. 8, pp. 887-895
Closed Access | Times Cited: 88
The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression
Xiangqian Gao, Cui-Yun Liu, Yuhui Zhang, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 3, pp. 527-539
Open Access | Times Cited: 59
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
Kai Guo, Zhiqiang Ma, Yujiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 41
The role of altered protein acetylation in neurodegenerative disease
Fariha Kabir, Rachel A.K. Atkinson, Anthony L. Cook, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 37
AMPK and HIF signaling pathways regulate both longevity and cancer growth: the good news and the bad news about survival mechanisms
Antero Salminen, Kai Kaarniranta, Anu Kauppinen
Biogerontology (2016) Vol. 17, Iss. 4, pp. 655-680
Closed Access | Times Cited: 76
Effects of novel HDAC inhibitors on urothelial carcinoma cells
Aline Kaletsch, Maria Pinkerneil, Michèle J. Hoffmann, et al.
Clinical Epigenetics (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 74
HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
Liqing Luo, Sherry C. Martin, Jascha Parkington, et al.
Cell Reports (2019) Vol. 29, Iss. 3, pp. 749-763.e12
Open Access | Times Cited: 74
HDAC9 exacerbates endothelial injury in cerebral ischaemia/reperfusion injury
Weichen Shi, Xinbing Wei, Ziying Wang, et al.
Journal of Cellular and Molecular Medicine (2016) Vol. 20, Iss. 6, pp. 1139-1149
Open Access | Times Cited: 72
Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma
Li-Si Zeng, Xian-Zi Yang, Yue-Feng Wen, et al.
Aging (2016) Vol. 8, Iss. 6, pp. 1236-1248
Open Access | Times Cited: 71
Complex neuroprotective and neurotoxic effects of histone deacetylases
Elizabeth A. Thomas, Santosh R. D’Mello
Journal of Neurochemistry (2018) Vol. 145, Iss. 2, pp. 96-110
Open Access | Times Cited: 67
Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders
Rohan Gupta, Rashmi K. Ambasta, Pravir Kumar
Life Sciences (2020) Vol. 243, pp. 117278-117278
Closed Access | Times Cited: 66
Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?
Angela De Simone, Andrea Milelli
ChemMedChem (2019) Vol. 14, Iss. 11, pp. 1067-1073
Closed Access | Times Cited: 58
The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
Saikat Dewanjee, V. Jayalakshmi, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1340-1340
Open Access | Times Cited: 50
Inactivating histone deacetylase HDA promotes longevity by mobilizing trehalose metabolism
Ruofan Yu, Xiaohua Cao, Luyang Sun, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target
Chun Cheng, Jun Yang, Siwei Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top